WallStreetZenWallStreetZen

NASDAQ: PODD
Insulet Corp Stock Forecast, Predictions & Price Target

Open Broker Account
OverviewForecast
EarningsDividendOwnership

Analyst price target for PODD

Based on 11 analysts offering 12 month price targets for Insulet Corp.
Min Forecast
$235.00+0.35%
Avg Forecast
$279.82+19.48%
Max Forecast
$325.00+38.78%

Should I buy or sell PODD stock?

Based on 11 analysts offering ratings for Insulet Corp.
Buy
Strong Buy
4 analysts 36.36%
Buy
4 analysts 36.36%
Hold
3 analysts 27.27%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their PODD stock forecasts and price targets.

PODD stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Morgan Stanley
Top 4%
97
HoldMaintains$273.00+16.57%2022-08-08
Canaccord Genuity
Top 14%
87
Strong BuyMaintains$290.00+23.83%2022-08-05Find out why
Baird
Top 16%
85
BuyMaintains$300.00+28.10%2022-08-05
Raymond James
Bottom 4%
4
BuyMaintains$280.00+19.56%2022-08-05
Piper Sandler
Bottom 6%
6
HoldMaintains$235.00+0.35%2022-08-05
Citigroup
Top 8%
93
HoldDowngrades$250.00+6.75%2022-07-11
BTIG
Top 8%
93
Strong BuyMaintains$250.00+6.75%2022-06-24
Anonymous
Morgan Stanley
HoldMaintains$244.00+4.19%2022-06-07
SVB Leerink
Bottom 3%
3
BuyMaintains$280.00+19.56%2022-05-06
BTIG
Top 10%
91
Strong BuyUpgrades$320.00+36.64%2022-02-03

1 of 2

Forecast return on equity

Is PODD forecast to generate an efficient return?
Company
56.03%
Industry
24.32%
Market
118.57%
PODD's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is PODD forecast to generate an efficient return on assets?
Company
11.2%
Industry
13.22%
PODD is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

PODD earnings per share forecast

What is PODD's earnings per share in the next 3 years based on estimates from 10 analysts?
Avg 1 year Forecast
$0.83+62.75%
Avg 2 year Forecast
$1.46+186.27%
Avg 3 year Forecast
$2.33+356.86%
PODD's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

PODD revenue forecast

What is PODD's revenue in the next 3 years based on estimates from 8 analysts?
Avg 1 year Forecast
$1.2B+4.81%
Avg 2 year Forecast
$1.5B+26.87%
Avg 3 year Forecast
$1.8B+51.3%
PODD's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

PODD earnings growth forecast

How is PODD forecast to perform vs Medical Devices companies and vs the US market?
Company
63.91%
Industry
19.69%
Market
16.42%
PODD's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
PODD's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
PODD's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

PODD revenue growth forecast

How is PODD forecast to perform vs Medical Devices companies and vs the US market?
Company
14.63%
Industry
4.76%
Market
8.46%
PODD's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
PODD's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

PODD vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
PODD$234.19$279.82+19.48%Buy
ALGN$222.43$367.50+65.22%Strong Buy
BIO$421.93$707.50+67.68%Strong Buy
ABMD$245.53$311.25+26.77%Hold
ZBH$106.21$133.94+26.11%Hold
View Top Medical Device Stocks

Insulet Stock Forecast FAQ

Is Insulet Stock a good buy in 2022, according to Wall Street analysts?

The consensus among 11 Wall Street analysts covering (NASDAQ: PODD) stock is to Buy PODD stock.

Out of 11 analysts, 4 (36.36%) are recommending PODD as a Strong Buy, 4 (36.36%) are recommending PODD as a Buy, 3 (27.27%) are recommending PODD as a Hold, 0 (0%) are recommending PODD as a Sell, and 0 (0%) are recommending PODD as a Strong Sell.

If you're new to stock investing, here's how to buy Insulet stock.

What is PODD's earnings growth forecast for 2022-2024?

(NASDAQ: PODD) Insulet's forecast annual earnings growth rate of 63.91% is forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 19.69%, and and it is also forecast to beat the US market's average forecast earnings growth rate of 16.42%.

Insulet's earnings in 2022 is $34,600,000.On average, 10 Wall Street analysts forecast PODD's earnings for 2022 to be $57,604,990, with the lowest PODD earnings forecast at $40,254,089, and the highest PODD earnings forecast at $96,471,007. On average, 11 Wall Street analysts forecast PODD's earnings for 2023 to be $101,329,259, with the lowest PODD earnings forecast at $82,590,286, and the highest PODD earnings forecast at $127,008,592.

In 2024, PODD is forecast to generate $161,710,393 in earnings, with the lowest earnings forecast at $138,113,168 and the highest earnings forecast at $186,001,653.

What is PODD's revenue growth forecast for 2022-2024?

(NASDAQ: PODD) Insulet's forecast annual revenue growth rate of 14.63% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 4.76%, and and it is also forecast to beat the US market's average forecast revenue growth rate of 8.46%.

Insulet's revenue in 2022 is $1,178,100,000.On average, 8 Wall Street analysts forecast PODD's revenue for 2022 to be $85,700,955,822, with the lowest PODD revenue forecast at $84,818,142,004, and the highest PODD revenue forecast at $86,686,486,970. On average, 8 Wall Street analysts forecast PODD's revenue for 2023 to be $103,734,163,133, with the lowest PODD revenue forecast at $101,819,942,386, and the highest PODD revenue forecast at $107,464,537,337.

In 2024, PODD is forecast to generate $123,706,576,488 in revenue, with the lowest revenue forecast at $120,308,367,923 and the highest revenue forecast at $126,779,559,773.

What is PODD's forecast return on assets (ROA) for 2022-2025?

(NASDAQ: PODD) forecast ROA is 11.2%, which is lower than the forecast US Medical Devices industry average of 13.22%.

What is PODD's Price Target?

According to 11 Wall Street analysts that have issued a 1 year PODD price target, the average PODD price target is $279.82, with the highest PODD stock price forecast at $325.00 and the lowest PODD stock price forecast at $235.00.

On average, Wall Street analysts predict that Insulet's share price could reach $279.82 by Aug 8, 2023. The average Insulet stock price prediction forecasts a potential upside of 19.48% from the current PODD share price of $234.19.

What is PODD's Earnings Per Share (EPS) forecast for 2022-2024?

(NASDAQ: PODD) Insulet's current Earnings Per Share (EPS) is $0.51. On average, analysts forecast that PODD's EPS will be $0.83 for 2022, with the lowest EPS forecast at $0.58, and the highest EPS forecast at $1.39. On average, analysts forecast that PODD's EPS will be $1.46 for 2023, with the lowest EPS forecast at $1.19, and the highest EPS forecast at $1.83. In 2024, PODD's EPS is forecast to hit $2.33 (min: $1.99, max: $2.68).

What is PODD's forecast return on equity (ROE) for 2022-2025?

(NASDAQ: PODD) forecast ROE is 56.03%, which is considered strong.
©2022 WallStreetZen
Company
AboutBlogPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContact
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market Industries
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
Social
TwitterYouTube
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.